Who owns ANGIODYNAMICS INC (ANGO)? Elite investor 13F holders
3 tracked elite investors reported holding ANGIODYNAMICS INC as of 2026-06-30, including Renaissance Technologies LLC, First Eagle Investment Management, Tudor Investment. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Health Care Equipment & Services
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | ANGIODYNAMICS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 9547818.00 USD | 733883.000000 | Shares | reduce | Original filing |
| First Eagle Investment Management | ANGIODYNAMICS INC | SHARE | 2026-06-30 | 2026-08-05 00:00:00 | 3596419.00 USD | 276435.000000 | Shares | add | Original filing |
| Tudor Investment | ANGIODYNAMICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 253084.00 USD | 19453.000000 | Shares | reduce | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.